Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048307 · ClinicalTrials.gov registry record · NA
Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
A NA study of Chronic Wound Care and Wound Care, sponsored by Calvary Hospital, Bronx, NY.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01048307: Completed NA study of Chronic Wound Care and Wound Care, sponsored by Calvary Hospital, Bronx, NY.
NCT01048307 is a NA study of Chronic Wound Care and Wound Care that has completed, run by Calvary Hospital, Bronx, NY. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01048307, a NA study of Chronic Wound Care and Wound Care, has completed, sponsored by Calvary Hospital, Bronx, NY.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Objective: To evaluate the efficacy and safety of Prontosan® Wound Irrigation Solution in the treatment of hard-to-heal venous leg ulcers compared to wound irrigation with saline solution Methodology: Randomised, controlled multi-centre, prospective clinical trial Planned number of subjects: 20 patients in experimental group (Prontosan® Wound Irrigation Solution) 8 patients in control group (wound irrigation with saline) Products under investigation: Prontosan® Wound Irrigation Solution Study Duration: 3-4 weeks
Conditions Studied
Interventions
- DEVICE Prontosan wound irrigation solution
Study Locations (1)
New York
- Calvary hospital center for curative and palliative wound care - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-07 |
| Phase | NA |
What the finished NCT01048307 record still lists
NCT01048307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Chronic Wound Care appearing as the primary indexed condition, and to 1 intervention - of which Prontosan wound irrigation solution is the first listed.
NCT01048307 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01048307 about?
NCT01048307 is a clinical study titled "Effect of Prontosan Wound Irrigation Solution on Venous Ulcers". Objective: To evaluate the efficacy and safety of Prontosan® Wound Irrigation Solution in the treatment of hard-to-heal venous leg ulcers compared to wound irrigation with saline solution Methodology: Randomised, controlled multi-centre, prospective clinical trial Planned number of subjects: 20...
What is the current status of trial NCT01048307?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-06. Estimated completion is 2010-07.
What conditions does trial NCT01048307 study?
This clinical trial studies the following conditions: Chronic Wound Care, Wound Care, Venous Ulcer Care, Wound Cleansing.
What interventions are being tested in trial NCT01048307?
The interventions under investigation include: Prontosan wound irrigation solution (DEVICE).
Who is sponsoring clinical trial NCT01048307?
This trial is sponsored by Calvary Hospital, Bronx, NY, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01048307 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Wound Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01048307's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia